Summary
Overview
Work History
Education
Skills
Websites
Selected Publications
Phone - Number
Languages
Timeline
Generic

Anna Juncker-Jensen

San Clemente,CA

Summary

Driven leader with a proven track record at NeoGenomics, adept at spearheading scientific affairs with a flair for adopting new technologies and enhancing service offerings. Excelled in content development for scientific marketing, bolstering sales through innovative lead generation strategies. Skilled in fostering relationships with key opinion leaders, blending strong communication skills with expertise in scientific technical support.

Overview

15
15
years of professional experience

Work History

Senior Director, Head of Scientific Affairs

NeoGenomics
01.2017 - Current
  • Lead a team of Scientific Affairs subject matter experts who provide advanced and relevant scientific and technical expertise as an integral part of NeoGenomics' Pharma Services Division.
  • Drive adoption of new technology platforms, modalities, and service offerings.
  • Support marketing initiatives by providing technical content for brochures, social media, and sales capabilities presentations.
  • Develop lead generation strategies, including content marketing, and trade shows.
  • Perform Pharma/Biotech pipeline analyses for sales presentations.
  • Create and sustain relationships with academia and industry KOLs, and thought leaders.
  • Support and execute R&D-focused projects and Pharma Services publication/scientific leadership strategy.

Senior Scientist

NantBioscience
01.2014 - 01.2017
  • Company Overview: Drug Discovery Group
  • Led a K-Ras project team responsible for the successful delivery of an optimized cancer drug candidate from hit optimization to the pre-clinical phase
  • Developed, utilized, and validated cell-based high-throughput bioassays in support of oncology drug development programs
  • Drug Discovery Group

Postdoctoral Researcher

Scripps Research Institute
La Jolla, CA
01.2010 - 01.2014
  • Company Overview: Department of Cell & Molecular Biology
  • Discovered a novel in vivo mechanism for MMP-1 promoting cancer intravasation
  • Developed a novel orthotopic murine head and neck cancer metastasis model
  • Department of Cell & Molecular Biology

Education

PhD - Cancer Cell Biology

The University of Copenhagen
01.2010

M.Sc. - Cancer Cell Biology

The University of Copenhagen
01.2007

Skills

  • Leading and motivating teams to achieve organizational goals
  • Content Development for Scientific Marketing
  • Sales support and lead generation
  • Strong written and verbal communication skills for presenting complex scientific content

Selected Publications

  • Changes in the immune landscape of TNBC after neoadjuvant chemotherapy: correlation with relapse., MR Moamin, R Allen, SL Woods, JE Brown, H Nunns, A Juncker-Jensen, CE Lewis., Front Immunol, 11/09/23, 14, 1291643
  • An integrated gene-to-outcome multimodal database for metabolic dysfunction-associated steatotic liver disease., TJ Kendall, M Jimenez-Ramos, F Turner, P Ramachandran, J Minnier, MD McColgan, M Alam, H Ellis, DR Dunbar, G Kohnen, P Konanahalli, KA Oien, L Bandiera, F Menolascina, A Juncker-Jensen, et al., Nature Med, 11/01/23, 29, 11, 2939-2953
  • Spatial relationship of tertiary lymphoid structures and tumor-associated neutrophils in bladder cancer and prognostic potential for anti-PD-L1 immunotherapy., X Wang & A Juncker-Jensen., Cancer Commun, 10/20/23
  • Host obesity alters the ovarian tumor immune microenvironment and impacts response to standard of care chemotherapy., Y Liu, J Yang, TS Hilliard, Z Wang, J Johnson, W Wang, EI Harper, C Ott, C O'Brien, L Campbell, B Crowley, S Grisoli, NM Stavrou, A Juncker-Jensen, MS Stack., J Exp Clin Cancer Res, 07/12/23, 42, 1, 165
  • Compositions and methods of targeting mutant K-Ras., Co-authored U.S. patent (WO 2016161361 A1)., 10/06/16
  • Tumor MMP-1 activates endothelial PAR1 to facilitate vascular intravasation and metastatic dissemination., A Juncker-Jensen, EI Deryugina, I Rimann, E Zajac, TA Kupriyanova, LH Engelholm, JP Quigley., Cancer Res, 07/15/13, 73, 14, 4196-211

Phone - Number

858-729-8296

Languages

English
Native/ Bilingual
Danish
Native/ Bilingual
Spanish
Limited
French
Limited
German
Limited

Timeline

Senior Director, Head of Scientific Affairs

NeoGenomics
01.2017 - Current

Senior Scientist

NantBioscience
01.2014 - 01.2017

Postdoctoral Researcher

Scripps Research Institute
01.2010 - 01.2014

PhD - Cancer Cell Biology

The University of Copenhagen

M.Sc. - Cancer Cell Biology

The University of Copenhagen
Anna Juncker-Jensen